Skip to main content
    D

    Doximity Inc (DOCS)

    Official site

    HEALTHCARE • HEALTH INFORMATION SERVICES • NYSE

    $32.79
    -0.55 (-1.65%)

    Market Cap: $5.95B

    Last updated: Nov 17, 2026 at 11:03 AM ET

    Doximity Inc (DOCS) P/E Ratio & Valuation History

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    Doximity (DOCS) trades at 31.2x trailing earnings and 8.9x sales. Its P/E of 31.2x is below its 5-year median of 39.4x. Its forward P/E is 24.5x. The median P/E across 8 similar companies is 31.1x.

    Current Multiples

    Its forward P/E is below its trailing P/E, which implies earnings per share about 27.3% higher over the next year. Its free cash flow yield is 5.1%.

    MultipleValue
    P/E (trailing)31.2x
    Forward P/E24.5x
    Price to sales8.9x
    Price to book6.3x
    EV/EBITDA25.2x
    Price to FCF19.7x
    EV/FCF19.0x
    PEG0.6
    FCF yield5.1%
    As of Nov 17, 2026

    Historical Medians

    MultipleCurrent5-year median10-year median
    P/E31.2x39.4xN/A
    P/S8.9x15.6xN/A
    P/B6.3x7.2xN/A
    Medians of month-end values through Oct 2026: 60 months (5-year).

    Valuation History

    Over the 5 year ends shown, its P/E ranged from 29.5x in 2025 to 77.1x in 2021. 2025 was the lowest of those years.

    Year endPriceP/EP/SP/B
    2025$44.2829.5x13.2x8.5x
    2024$53.3941.7x18.4x9.7x
    2023$28.0431.2x11.7x6.0x
    2022$33.5645.4x16.5x7.0x
    2021$50.1377.1x23.7x11.3x
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported; periods with losses are left out.

    GNG Valuation

    GNG viewOvervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About DOCS

    What is DOCS's forward P/E ratio?

    Doximity has a forward P/E ratio of 24.5x.

    Is DOCS stock overvalued?

    GNG's valuation label for DOCS is Overvalued. Its P/E of 31.2x compares with a median of 31.1x across 8 similar companies.

    What is DOCS's price to sales ratio?

    Doximity has a price to sales ratio of 8.9x.

    What is Doximity's average P/E ratio over 5 years?

    Doximity's median P/E over the last 5 years is 39.4x, from 60 month-end values through Oct 2026.

    What is DOCS's PEG ratio?

    Doximity has a PEG ratio of 0.6.